OLR1 and Stroke: It turns out to be that serum sLOX‐1 levels were significantly higher in the moderate stroke patients compared to the mild stroke group (2.43 ± 0.75 ng/ml vs. 2.16 ± 0.84 ng/ml, p = .011).